| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Gen Counsel &Corp Sec | SVP, Gen Counsel &Corp Sec
1 company
Eydelman Mikhail is a SVP, Gen Counsel &Corp Sec at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $72.06 | $120,127.22 | -1.7% | +52.5% | -52.0% | |
| May 1, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $61.74 | $102,921.27 | -1.8% | +25.4% | -44.7% | |
| Apr 1, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $66.73 | $111,234.14 | -2.6% | +15.3% | -51.7% | |
| Mar 1, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $73.73 | $122,906.84 | -1.7% | -2.1% | +1.8% | |
| Feb 1, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $73.87 | $123,143.91 | -1.9% | -15.6% | +16.9% | |
| Jan 2, 2024 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $63.93 | $106,578.89 | -2.5% | +6.0% | +32.3% | |
| Dec 7, 2023 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 10,000 | $56.50 | $565,000.00 | -32.2% | +25.4% | +64.3% | |
| Oct 2, 2023 | PCVX Vaxcyte, Inc. | SVP, Gen Counsel &Corp Sec | Sale+OE | 20,000 | $50.40 | $1,007,988.60 | -19.9% | +28.3% | +135.6% |